IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Inotek Pharmaceuticals Corp

CUSIP: 45780VAA0 | 11 institutional holders

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Opaleye Management Inc.400,000
0.0% of portfolio›$3.8K
StyleTurnoverLocationFiled
Opaleye Management Inc.
400,000$3.8K0.0%Agg GrowthMediumBoston, MA2016-11-14